NASDAQ:PDEX Pro-Dex Q4 2026 Earnings Results & Report $58.67 +0.41 (+0.70%) As of 11:24 AM Eastern This is a fair market value price provided by Massive. Learn more. Pro-Dex beat analyst expectations on both earnings and revenue in its Q4 2026 results, released September 3, 2026. The company reported EPS of $0.87 versus the $0.67 consensus estimate, while revenue of $20.41 million topped the $19.20 million estimate by $1.21 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ4 2026Report DateSeptember 3, 2026TimeAfter Market ClosesConference Call7:00 AM ET Pro-Dex EPS ResultsActual EPS$0.87Consensus EPS $0.67Beat/MissBeat by +$0.20One Year Ago EPSN/AEPS Beat Rate7 of last 8 quartersPro-Dex Revenue ResultsActual Revenue$20.41 millionExpected Revenue$19.20 millionBeat/MissBeat by +$1.21 millionYoY Revenue GrowthN/AUpcoming EarningsPro-Dex's Q1 2027 earnings is estimated for Thursday, October 29, 2026, based on past reporting schedules, with a conference call scheduled on Friday, October 30, 2026 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesPress Release (8-K)Annual Report (10-K)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Annual report(10-K) Pro-Dex Q4 2026 Earnings FAQ Did Pro-Dex beat earnings estimates for Q4 2026? Pro-Dex (NASDAQ:PDEX) reported earnings of $0.87 per share for Q4 2026, beating the consensus estimate of $0.67. The report was announced on Thursday, September 3, 2026. What was Pro-Dex's revenue for Q4 2026? Pro-Dex reported revenue of $20.41 million for Q4 2026, against a consensus estimate of $19.20 million. When is Pro-Dex's next earnings date? Pro-Dex's next earnings date is estimated for Thursday, October 29, 2026. MarketBeat tracks confirmed and estimated earnings dates for Pro-Dex on the company's earnings history page. Pro-Dex Earnings HeadlinesPro-Dex (NASDAQ:PDEX) Stock Breaks Below 200-Day Moving Average - Here's WhyOctober 16 at 2:41 AM | americanbankingnews.comReviewing Pro-Dex (NASDAQ:PDEX) & Bausch + Lomb (NYSE:BLCO)October 8, 2026 | americanbankingnews.comLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.October 19 at 1:00 AM | InvestorPlace (Ad)5 Biotech And Medical Device Stocks In Focus: Pro-Dex, Modular Medical, ENvue Medical & MoreSeptember 4, 2026 | rttnews.comPro-Dex Jumps On Higher Q4 Earnings And Revenue GrowthSeptember 4, 2026 | rttnews.comPro-Dex Inc (PDEX) Positioned to Strengthen with Zimmer’s mBos Robot CommercializationAugust 10, 2026 | insidermonkey.comSee More Pro-Dex Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Pro-Dex? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pro-Dex and other key companies, straight to your email. Email Address About Pro-DexPro-Dex (NASDAQ:PDEX) is a medical device company that designs, develops and manufactures powered surgical instruments and related equipment. Its products are primarily used in orthopedic, dental and other surgical procedures, where precision, reliability and controlled power are important. The company supplies instruments and components to original equipment manufacturers and other medical device customers. Its capabilities include product design and development, engineering, manufacturing, assembly and related support services. Pro-Dex’s offerings include powered handpieces, drive systems and associated electronic or mechanical components used in specialized surgical applications. Pro-Dex is headquartered in Irvine, California, and serves customers in the medical device industry in the United States and international markets. The company operates primarily as a business-to-business manufacturer, with its products generally incorporated into or marketed through customers’ medical device platforms and product lines.View Pro-Dex ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Rate-Resilient vs. Rate-Exposed: Why Homebuilder Stocks Are DivergingMarketBeat Week in Review – 10/12 - 10/16Could a Trucking Squeeze Become J.B. Hunt’s Biggest Edge?Meta Claims Frontier-Class AI Status With New Muse Wonder ModelsMicrosoft's New AI Chip Could Change the Economics of AIThese 3 Green Stocks Have a Growth Story That Goes Far Beyond WashingtonWomen Drive the Job Market—These 3 Stocks Are Following Them Upcoming Earnings America Movil (10/20/2026)Netflix (10/20/2026)General Motors (10/20/2026)Chubb (10/20/2026)Capital One Financial (10/20/2026)Intuitive Surgical (10/20/2026)GE Aerospace (10/20/2026)3M (10/20/2026)Northrop Grumman (10/20/2026)RTX (10/20/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
